In this supplement:
- Stefano Fazzini (Tor Vergata Hospital, Rome, Italy) goes into the details and the data behind Shockwave Intravascular Lithotripsy (IVL; Shockwave Medical)—a technology he states is “changing the boundaries” in peripheral arterial disease (PAD).
- Raphaël Coscas (Ambroise Paré Hospital, AP-HP and Paris-Saclay University, Paris, France) illustrates the use and benefits of Shockwave IVL in a common femoral artery (CFA) case. Owing in large part to the therapy’s ability to modify vessel compliance, Coscas believes endovascular repair of the CFA using IVL as the main preparation tool for calcified lesions “should be discussed routinely”. Click here to view corresponding video interview.
- Narayanan Thulasidasan (Guy’s & St Thomas’ NHS Foundation Trust, London, UK) demonstrates how the M5+ IVL catheter (Shockwave Medical) has transformed endovascular treatment options for the CFA, “opening up minimally invasive therapy to many more patients considered high risk for open surgery without compromising on effectiveness”. Click here to view corresponding video interview.
- Bella Huasen (Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK) outlines a recent femoropopliteal occlusion case, during which Shockwave IVL proved to be an effective vessel preparation strategy in this ‘no-stent zone’. Click here to view corresponding video interview.
- Giacomo Isernia and Gioele Simonte (Azienda Ospedaliera di Perugia, Perugia, Italy) outline a branched endovascular aneurysm repair (BEVAR) case in which the M5+ IVL catheter was “effective in modifying arterial compliance to provide luminal gain and reduce procedural complications”. Click here to view corresponding video interview.